Teva Pharmaceutical Industries Ltd. ADR-1.50% $19.99B ...

“We are very impressed with Syngene’s professionalism, commitment to scientific excellence, and ability to deliver high-quality work on time,” said Allan Wehnert, CEO & Founder of Orocidin. “This ...

Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90. The company’s shares opened today at p1,443. ...

Identifies dividend-paying stocks with strong profitability, appealing to income-oriented investors seeking quality and value. Screens stocks with Dividend Yield above 3%, Net Profit Margin exceeding ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Vaccine makers face a demand cliff as coronavirus vaccines wane, but these stocks are more than meets the eye.

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

GSK's revenue and EPS exceeded my expectations and those of analysts, thanks to the strong performance of its oncology and HIV franchises. So, Ojjaara/Omjjara sales amounted to $150 million in the ...

They’re top quality but are accessibly priced ... Price point can be a little high If you enjoy quiet luxury, this logo-centric brand may not be for you This is another super-recognizable ...

GSK shares added ~6% in London trading on Wednesday after the British drugmaker lifted its 2031 outlook and announced a new share buyback program alongside better-than-expected earnings for Q4 ...